Profile | GDS4284 / 219863_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1237.03 | 77 |
GSM687648 | Patient 402 control | 501.868 | 64 |
GSM687653 | Patient 403 control | 1163.19 | 76 |
GSM687658 | Patient 404 control | 3365.41 | 90 |
GSM687663 | Patient 411 control | 1832.99 | 83 |
GSM687668 | Patient 422 control | 1295.78 | 78 |
GSM687673 | Patient 424 control | 3306.01 | 90 |
GSM687678 | Patient 425 control | 876.066 | 71 |
GSM687683 | Patient 427 control | 1486.93 | 80 |
GSM687688 | Patient 428 control | 835.19 | 71 |
GSM687695 | Patient 441 control | 3080.02 | 90 |
GSM687699 | Patient 443 control | 907.542 | 72 |
GSM687704 | Patient 444 control | 409.025 | 61 |
GSM687707 | Patient 448 control | 1246.22 | 78 |
GSM687712 | Patient 449 control | 1374.73 | 79 |
GSM687719 | Patient 450 control | 2308.95 | 86 |
GSM687724 | Patient 451 control | 2404.52 | 86 |
GSM687728 | Patient 452 control | 903.056 | 73 |
GSM687646 | Patient 401 treated 24h | 1330.38 | 78 |
GSM687649 | Patient 402 treated 24h | 462.176 | 62 |
GSM687665 | Patient 411 treated 24h | 1476.62 | 80 |
GSM687651 | Patient 402 treated 4 weeks | 582.121 | 65 |
GSM687667 | Patient 411 treated 4 weeks | 1707.26 | 81 |
GSM687670 | Patient 422 treated 24h | 1250.67 | 77 |
GSM687671 | Patient 422 treated 4 weeks | 1264.93 | 77 |
GSM687654 | Patient 403 treated 24h | 1485.18 | 80 |
GSM687675 | Patient 424 treated 24h | 2392.78 | 86 |
GSM687685 | Patient 427 treated 24h | 1443.56 | 79 |
GSM687656 | Patient 403 treated 4 weeks | 999.937 | 74 |
GSM687677 | Patient 424 treated 4 weeks | 2857.75 | 88 |
GSM687687 | Patient 427 treated 4 weeks | 1114.24 | 75 |
GSM687692 | Patient 428 treated 4h | 837.74 | 71 |
GSM687716 | Patient 449 treated 4h | 914.972 | 73 |
GSM687722 | Patient 450 treated 4h | 2250.39 | 86 |
GSM687680 | Patient 425 treated 24h | 875.984 | 72 |
GSM687690 | Patient 428 treated 24h | 946.419 | 74 |
GSM687700 | Patient 443 treated 24h | 1885.44 | 83 |
GSM687705 | Patient 444 treated 24h | 696.939 | 69 |
GSM687714 | Patient 449 treated 24h | 1241.46 | 78 |
GSM687721 | Patient 450 treated 24h | 2666 | 88 |
GSM687682 | Patient 425 treated 4 weeks | 1126.11 | 76 |
GSM687694 | Patient 428 treated 4 weeks | 832.245 | 71 |
GSM687702 | Patient 443 treated 4 weeks | 754.859 | 69 |
GSM687718 | Patient 449 treated 4 weeks | 1058.4 | 75 |
GSM687723 | Patient 450 treated 4 weeks | 1667.04 | 82 |
GSM687661 | Patient 404 treated 4h | 2588.87 | 87 |
GSM687710 | Patient 448 treated 4h | 974.104 | 74 |
GSM687726 | Patient 451 treated 4h | 2096.77 | 85 |
GSM687730 | Patient 452 treated 4h | 2290.26 | 87 |
GSM687660 | Patient 404 treated 24h | 16314.9 | 98 |
GSM687697 | Patient 441 treated 24h | 2459.9 | 87 |
GSM687709 | Patient 448 treated 24h | 1309.71 | 78 |
GSM687725 | Patient 451 treated 24h | 1953.42 | 84 |
GSM687729 | Patient 452 treated 24h | 517.192 | 64 |
GSM687727 | Patient 451 treated 4 weeks | 2580.5 | 87 |
GSM687731 | Patient 452 treated 4 weeks | 5877.19 | 95 |